Frontiers in Immunology | Cancer Immunity and Immunotherapy

Editorial

Published on 24 Sep 2024

Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategies

in Cancer Immunity and Immunotherapy

Elizabeth Quackenbush
Jyothi Vijayaraghavan
Emrah Ilker Ozay
Rui-Ru Ji

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491982

541 views

Original Research

Published on 24 Sep 2024

Novel prognostic signature for hepatocellular carcinoma using a comprehensive machine learning framework to predict prognosis and guide treatment

in Cancer Immunity and Immunotherapy

Shengzhou Zheng
Zhixiong Su
Yufang He
Lijie You
Guifeng Zhang
Jingbo Chen
Lihu Lu
Zhenhua Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454977

2,504 views

Systematic Review

Published on 24 Sep 2024

Global research trends and focus on the link between neutrophil extracellular traps and tumor: a bibliometric and visualization analysis from 2006 to 2024

in Cancer Immunity and Immunotherapy

Chaoyue Xiao
Xiang Feng
Zengyi Zhao
Gouping Ding
Yawen Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452104

2,372 views
1 citation

Original Research

Published on 24 Sep 2024

Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas

in Cancer Immunity and Immunotherapy

Zigui Chen
Chao Liu
Chunyuan Zhang
Ying Xia
Jun Peng
Changfeng Miao
Qisheng Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475206

1,597 views
1 citation

Original Research

Published on 24 Sep 2024

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

in Cancer Immunity and Immunotherapy

Lanting Liu
Dasen Gong
Hao Sun
Fangshuo Feng
Jie Xu
Xiyue Sun
Lixin Gong
Zhen Yu
Teng Fang
Yan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470328

2,244 views

Review

Published on 24 Sep 2024

Interleukin signaling in the regulation of natural killer cells biology in breast cancer

in Cancer Immunity and Immunotherapy

Jiachi Xu
Hongyu Gao
Muhammad Salman Azhar
Haifan Xu
Siyuan Chen
Mingcan Li
Xinxi Ni
Ting Yan
Hui Zhou
Qian Long

Frontiers in Immunology

doi 10.3389/fimmu.2024.1449441

1,941 views

Original Research

Published on 24 Sep 2024

Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models

in Cancer Immunity and Immunotherapy

Yutong Fang
Qunchen Zhang
Cuiping Guo
Rongji Zheng
Bing Liu
Yongqu Zhang
Jundong Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461489

2,766 views
1 citation

Original Research

Published on 23 Sep 2024

Mucosal microbiota characterization in gastric cancer identifies immune-activated–related transcripts relevant gastric microbiome signatures

in Cancer Immunity and Immunotherapy

Chengjia Qian
Jiang Hui
Ziyao Peng
Xiaoyan Sun
Jiali Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435334

1,737 views

Original Research

Published on 23 Sep 2024

Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer

in Cancer Immunity and Immunotherapy

Ralph J. A. Maas
Janneke S. Hoogstad-van Evert
Iris M. Hagemans
Jolanda Brummelman
Diede van Ens
Paul K. J. D. de Jonge
Laura Hooijmaijers
Shweta Mahajan
Anniek B. van der Waart
Charlotte K. J. C. Hermans

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448041

1,971 views

Clinical Trial

Published on 23 Sep 2024

Opioid−free anesthesia attenuates perioperative immunosuppression by regulating macrophages polarization in gastric cancer patients treated with neoadjuvant PD-1 inhibitor

in Cancer Immunity and Immunotherapy

Wenjian Liu
Chaopeng Ou
Ruifeng Xue
Xiaohua Yang
Yaqi Ye
Xudong Wang
Jingdun Xie

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438859

1,729 views
1 citation

Systematic Review

Published on 23 Sep 2024

Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Bo Pei
Jue Zhang
Lin Lai
Hui Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1393925

1,168 views

Editorial

Published on 23 Sep 2024

Editorial: Immunotherapeutic strategies to target cancer stem cells: state of the art in basic research to clinical application

in Cancer Immunity and Immunotherapy

Amirhesam Babajani
Marzieh Naseri
Faezeh Vakhshiteh
Roya Ghods
Zahra Madjd

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490569

922 views

Original Research

Published on 23 Sep 2024

Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic cancer

in Cancer Immunity and Immunotherapy

Bo Ren
Jie Ren
Minzhi Gu
Xiaohong Liu
Lei You
Yupei Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435593

1,363 views

Original Research

Published on 23 Sep 2024

Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma

in Cancer Immunity and Immunotherapy

Haotian Wang
Ying Zhang
Zhaoxia Li
Ou Bai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466859

1,095 views

Original Research

Published on 23 Sep 2024

Increased neutrophil counts are associated with poor overall survival in patients with colorectal cancer: a five-year retrospective analysis

in Cancer Immunity and Immunotherapy

Libia Alejandra Garcia-Flores
María Teresa Dawid De Vera
Jesus Pilo
Alejandro Rego
Gema Gomez-Casado
Isabel Arranz-Salas
Isabel Hierro Martín
Julia Alcaide
Esperanza Torres
Almudena Ortega-Gomez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415804

1,640 views

Review

Published on 20 Sep 2024

Generating advanced CAR-based therapy for hematological malignancies in clinical practice: targets to cell sources to combinational strategies

in Cancer Immunity and Immunotherapy

Shu Zhou
Yuhang Yang
Yulu Jing
Xiaoying Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435635

1,326 views
1 citation

Navigation group

Articles

Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategies

Novel prognostic signature for hepatocellular carcinoma using a comprehensive machine learning framework to predict prognosis and guide treatment

Global research trends and focus on the link between neutrophil extracellular traps and tumor: a bibliometric and visualization analysis from 2006 to 2024

Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

Interleukin signaling in the regulation of natural killer cells biology in breast cancer

Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models

Mucosal microbiota characterization in gastric cancer identifies immune-activated–related transcripts relevant gastric microbiome signatures

Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer

Opioid−free anesthesia attenuates perioperative immunosuppression by regulating macrophages polarization in gastric cancer patients treated with neoadjuvant PD-1 inhibitor

Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis

Editorial: Immunotherapeutic strategies to target cancer stem cells: state of the art in basic research to clinical application

Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic cancer

Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma

Increased neutrophil counts are associated with poor overall survival in patients with colorectal cancer: a five-year retrospective analysis

Generating advanced CAR-based therapy for hematological malignancies in clinical practice: targets to cell sources to combinational strategies